Item 8.01 Other Events.

On August 20, 2020, Organicell issued a press release in which it announced that the U.S. Food and Drug Administration (FDA) granted emergency, expanded access approval to treat one "long-hauler" patient on August 1, 2020, and two additional patient approvals on August 17, 2020.

A copy of the Company's press release dated August 20, 2020 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

© Edgar Online, source Glimpses